| Structure |
Chemical Name |
CAS |
MF |
 |
Ethyl 3,4-O-Isopropylidene-5-O-methanesulfonylshikimate |
204254-84-2 |
C13H20O7S |
![2-PyrazinecarboxaMide, N,N',N''-[2,4,6-boroxintriyltris[[(1R)-3-Methylbutylidene]iMino[(1S)-2-oxo-1-(phenylMethyl)-2,1-ethanediyl]]]tris-](/CAS/20180808/GIF/390800-88-1.gif) |
2-PyrazinecarboxaMide, N,N',N''-[2,4,6-boroxintriyltris[[(1R)-3-Methylbutylidene]iMino[(1S)-2-oxo-1-(phenylMethyl)-2,1-ethanediyl]]]tris- |
390800-88-1 |
C57H69B3N12O9 |
![Salmeterol Related Compound B (10 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol)](/CAS/GIF/108928-81-0.gif) |
Salmeterol Related Compound B (10 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol) |
108928-81-0 |
C25H37NO4 |
![3-[3-(ピペリジノメチル)フェノキシ]-1-プロパンアミン](/CAS/GIF/73278-98-5.gif) |
3-[3-(ピペリジノメチル)フェノキシ]-1-プロパンアミン |
73278-98-5 |
C15H24N2O |
 |
7,10-Bis-O-(2,2,2-trichloroethoxycarbonyl)-10-deacetylbaccatin III |
95603-44-4 |
C35H38Cl6O14 |
 |
4-(3-AMino-phenyl)-Morpholin-3-one |
1082495-22-4 |
C10H12N2O2 |
 |
piperacillinylaMpicillin |
|
|
|
|
Celecoxib iMpurity-B |
|
|
|
|
EMtricitabine iMpurity B |
|
|
![(S,S)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,6,8,12-tetrone](/CAS/GIF/14842-41-2.gif) |
(S,S)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,6,8,12-tetrone |
14842-41-2 |
C10H10N2O4 |
 |
BroMhexine Hydrochloride iMpurity DN-(2-AMino-5-broMobenzyl)-N-MethylcyclohexanaMine Dihydrochloride |
132004-28-5 |
C14H21BrN2 |
 |
2-(DiMethylcarbaMoyl)benzoic acid, 97% |
20320-37-0 |
C10H11NO3 |
 |
RAC DESMETHYL CITALOPRAM HYDROCHLORIDE |
97743-99-2 |
C19H19FN2O |
 |
2-Demethoxy-4-methoxy urapidil |
34661-79-5 |
C20H29N5O3 |
 |
1-(5-O-アセチル-β-D-リボフラノシル)-1H-1,2,4-トリアゾール-3-カルボアミド |
58151-87-4 |
C10H14N4O6 |
![4-[-((-((4-(5-(Bis(2-hydroxyethyl)aMino)-1-Methyl-1H-benzo[d]iMidazol-2-yl)butanoyl)oxy)ethyl)(2-hydroxyethyl)aMino)-1-Methyl-1H-benzo[d]iMidazol-2-yl)butanic Acid](/CAS/GIF/1228551-91-4.gif) |
4-[-((-((4-(5-(Bis(2-hydroxyethyl)aMino)-1-Methyl-1H-benzo[d]iMidazol-2-yl)butanoyl)oxy)ethyl)(2-hydroxyethyl)aMino)-1-Methyl-1H-benzo[d]iMidazol-2-yl)butanic Acid |
1228551-91-4 |
C32H41Cl3N6O4 |
![3-(6,7-Dihydro-2-Methyl-7-oxo-3-propyl-2H-pyrazolo[4,3-d]pyriMidin-5-yl)-4-ethoxy-benzenesulfonyl Chloride](/CAS/GIF/501120-42-9.gif) |
3-(6,7-Dihydro-2-Methyl-7-oxo-3-propyl-2H-pyrazolo[4,3-d]pyriMidin-5-yl)-4-ethoxy-benzenesulfonyl Chloride |
501120-42-9 |
C17H19ClN4O4S |
![(3R,4S)-rel-3-[(1,3-Benzodioxol-5-yloxy)Methyl]-4-(4'-fluoro[1,1'-biphenyl]-4-yl)-piperidine Hydrochloride](/CAS/GIF/1217655-87-2.gif) |
(3R,4S)-rel-3-[(1,3-Benzodioxol-5-yloxy)Methyl]-4-(4'-fluoro[1,1'-biphenyl]-4-yl)-piperidine Hydrochloride |
1217655-87-2 |
C25H24FNO3.ClH |
![[(1-エチルピペリジン-3-イル)メチル]アミン](/CAS/GIF/102459-02-9.gif) |
[(1-エチルピペリジン-3-イル)メチル]アミン |
102459-02-9 |
C8H18N2 |
 |
8-ヒドロキシミルタザピン |
102335-57-9 |
C17H19N3O |
 |
1-(1-(4-(ベンジルオキシ)フェニル)-2-(ジメチルアミノ)エチル)シクロヘキサノール |
93413-61-7 |
C23H31NO2 |
 |
N-Deshydroxyethyl Dasatinib |
910297-51-7 |
C20H22ClN7OS |
 |
N-デスエチルスニチニブ |
356068-97-8 |
C20H23FN4O2 |
 |
3-O-TERT-ブチルジメチルシリルカルシフェジオール |
140710-90-3 |
C33H58O2Si |
 |
3-Hydroxy loratadine |
183483-15-0 |
C22H23ClN2O3 |
![2-[2,6-ジメチル-3,5-ビス(エトキシカルボニル)-4-ピリジル]けい皮酸t(yī)ert-ブチル](/CAS/GIF/130996-24-6.gif) |
2-[2,6-ジメチル-3,5-ビス(エトキシカルボニル)-4-ピリジル]けい皮酸t(yī)ert-ブチル |
130996-24-6 |
C26H31NO6 |
 |
Granisetron Impurity F |
1364914-39-5 |
C18H24N4O |
![Budesonide Related Compound L (16alpha,17-[butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione)](/CAS/20180808/GIF/216453-74-6.gif) |
Budesonide Related Compound L (16alpha,17-[butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione) |
216453-74-6 |
C25H32O6 |
 |
6(S)-Hydroperoxy Simvastatin |
149949-01-9 |
C25H38O7 |
 |
6,7-ジメチル-8-リビチルルマジン |
2535-20-8 |
C13H18N4O6 |
![2-[(1-Benzylpiperidin-4-yl)hydroxyMethyl]-5,6-diMethoxyindan-1-one](/CAS/GIF/197010-20-1.gif) |
2-[(1-Benzylpiperidin-4-yl)hydroxyMethyl]-5,6-diMethoxyindan-1-one |
197010-20-1 |
C24H29NO4 |
 |
5,6-TRANS-ビタミンD2 |
51744-66-2 |
C28H44O |
 |
2-isonicotinoyl-5,6-diMethoxy-2,3-dihydro-1H-inden-1-one |
923571-15-7 |
C17H15NO4 |
 |
4-(2-nitrophenyl)Morpholin-3-one |
845729-41-1 |
C10H10N2O4 |
 |
Irbesartan IMpurity E |
|
C25H28N6O |
 |
LeflunoMide EP IMpurity G |
724429-16-7 |
C12H12N2O2 |
|
|
Telmisartan impurity C |
|
|
|
|
Itraconazole iMpurity E |
|
|
![N-(5-クロロ-2-ピリジル)-N'-[(1R,2R,4R)-4-(ジメチルカルバモイル)-2-[(5-メチル-6,7-ジヒドロ-4H-チアゾロ[5,4-C]ピリジン-2-カルボニル)アミノ]シクロヘキシル]オキサミド](/CAS/20150408/GIF/1255529-24-8.gif) |
N-(5-クロロ-2-ピリジル)-N'-[(1R,2R,4R)-4-(ジメチルカルバモイル)-2-[(5-メチル-6,7-ジヒドロ-4H-チアゾロ[5,4-C]ピリジン-2-カルボニル)アミノ]シクロヘキシル]オキサミド |
1255529-24-8 |
C24H30ClN7O4S |
 |
1,4,7,10-テトラアザシクロドデカン-1,7-二酢酸 |
112193-75-6 |
C12H24N4O4 |
![7-ethyl-5H-chroMeno[2,3-b]pyridin-5-one](/CAS/GIF/53944-31-3.gif) |
7-ethyl-5H-chroMeno[2,3-b]pyridin-5-one |
53944-31-3 |
C14H11NO2 |
 |
4-アミノ-2-メチル-10H-チエノ(2,3-B)(1,5)-ベンゾジアゼピン |
612503-08-9 |
C12H11N3S |
|
|
IMp. A (EP): 8-Chloro-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one |
|
|
|
|
IMp. C (EP): 8-Chloro-11-(piperazin-1-yl)-5H- dibenzo[b,e][1,4]diazepine |
|
|
 |
21-Dehydro-16α-hydroxy Prednisolone |
1188271-73-9 |
C21H26O6 |
 |
(6α,11β)-11,20-Dihydroxy-6-Methyl-3-oxopregna-1,4,17(20)-trien-21-al |
1338549-02-2 |
C22H28O4 |
 |
(1R)-2-chloro-1-(3,4-difluorophenyl)-1-ethanol |
1212376-05-0 |
C8H7ClF2O |
![2-[[(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol](/CAS/20150408/GIF/376608-75-2.gif) |
2-[[(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol |
376608-75-2 |
C17H24ClN5O4S |
 |
Fluconazole IMpurity F |
|
C13H12F2N6O |
 |
cefaclor iMpurity C |
143059-69-2 |
C15H14ClN3O4S |
|
|
ceftazidiMe iMpurity B |
1236700-64-3 |
|
 |
pidotiMod iMpurity D |
162148-15-4 |
C9H12N2O4S |
 |
Irinotecan Hydroxyl Acid |
142677-15-4 |
C22H22N2O6 |
 |
CyclopropanaMine, 2-(4-fluorophenyl)-(hydrochloride)(1:1),(1R,2S)- |
1314324-00-9 |
C9H11ClFN |
 |
Solifenacin N-Oxide |
180272-28-0 |
C23H26N2O3 |
 |
2-chloro-N-(4-ethoxyphenyl)-4-nitrobenzamide |
328258-90-8 |
C15H13ClN2O4 |
 |
N-(4-ヒドロキシフェニル)プロパンアミド |
1693-37-4 |
C9H11NO2 |
 |
2-クロロ-N-(3-クロロ-2-メチルフェニル)ニコチンアミド |
57841-61-9 |
C13H10Cl2N2O |
 |
(3R)-3-フェニル-β-アラニン |
13921-90-9 |
C9H11NO2 |
 |
4-(2-エトキシベンズアミド)-1-メチル-3-N-プロピルピラゾール-5-カルボキサミド |
139756-03-9 |
C17H22N4O3 |
 |
N-Hydroxy Riluzole |
179070-90-7 |
C8H5F3N2O2S |
 |
2-piperazine-4-amino-6,7-dimethoxyquinazoline Hydrochloride |
70843-11-7 |
C14H20ClN5O2 |
 |
3-(1-アジリジニル)プロピルアミン |
1072-65-7 |
C5H12N2 |
 |
3,5-ジ(4-ピリジニル)-1H-1,2,4-トリアゾール-1-アミン |
4923-06-2 |
C12H10N6 |
![(1α,2β,4β,5α)-9-メチル-3-オキサ-9-アザトリシクロ[3.3.1.02,4]ノナン-7α-オール](/CAS/20180808/GIF/498-46-4.gif) |
(1α,2β,4β,5α)-9-メチル-3-オキサ-9-アザトリシクロ[3.3.1.02,4]ノナン-7α-オール |
498-46-4 |
C8H13NO2 |
![(1α,4β)-4-[[6,8-ジブロモ-1,4-ジヒドロキナゾリン]-3(2H)-イル]シクロヘキサノール](/CAS/GIF/18683-95-9.gif) |
(1α,4β)-4-[[6,8-ジブロモ-1,4-ジヒドロキナゾリン]-3(2H)-イル]シクロヘキサノール |
18683-95-9 |
C14H18Br2N2O |
 |
16-ヒドロキシエリスロマイシン |
82230-93-1 |
C37H67NO14 |
![4-[1-(4-クロロフェニル)-1-フェニルエトキシ]-1-メチルヘキサヒドロ-1H-アゼピン](/CAS/GIF/61771-18-4.gif) |
4-[1-(4-クロロフェニル)-1-フェニルエトキシ]-1-メチルヘキサヒドロ-1H-アゼピン |
61771-18-4 |
C21H26ClNO |
 |
1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)-3,5-ピリジンジカルボン酸3-(2-ヒドロキシエチル)5-イソプロピル |
82219-47-4 |
C20H24N2O7 |
![3-[(3-トリフルオロメチル)フェニル]-1-プロペン](/CAS/GIF/1813-96-3.gif) |
3-[(3-トリフルオロメチル)フェニル]-1-プロペン |
1813-96-3 |
C10H9F3 |
![(AS)-A-(2-CHLOROPHENYL)-2,3,6,7-TETRAHYDRO-2-OXO-THIENO[3,2-C]PYRIDINE-5(4H)-ACETIC ACID METHYL ESTER](/CAS/GIF/527687-26-9.gif) |
(AS)-A-(2-CHLOROPHENYL)-2,3,6,7-TETRAHYDRO-2-OXO-THIENO[3,2-C]PYRIDINE-5(4H)-ACETIC ACID METHYL ESTER |
527687-26-9 |
C16H16ClNO3S |
 |
6-デオキシペンシクロビル |
104227-86-3 |
C10H15N5O2 |
![1,4,8,11-Tetrakis[(4-methylphenyl)sulfonyl]-1,4,8,11-tetraazacyclotetradecane](/CAS2/GIF/71089-74-2.gif) |
1,4,8,11-Tetrakis[(4-methylphenyl)sulfonyl]-1,4,8,11-tetraazacyclotetradecane |
71089-74-2 |
C38H48N4O8S4 |
 |
3-Cyano-4-isobutoxybenzoic acid |
528607-60-5 |
C12H13NO3 |
 |
REF DUPL: trans-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane |
139757-68-9 |
C8H11N3O3S |
 |
2-(4-モルホリノ-1,2,5-チアジアゾール-3-イルオキシ)-3-(tert-ブチルアミノ)-1-プロパノール |
59697-06-2 |
C13H24N4O3S |
 |
rac Cetirizine N-Oxide > 70% by HPLC
(Mixture of Diastereomers) |
1076199-80-8 |
C21H25ClN2O4 |
 |
(S)-N-Didemethyl Dapoxetine |
147199-40-4 |
C19H19NO |
 |
Hydroxy Flunarizine |
87166-81-2 |
C26H26F2N2O |
 |
1-METHYL-4-NITRO-3-PROPYL-1H-PYRAZOLE-5-CARBOXYLIC ACID |
139756-00-6 |
C8H11N3O4 |
 |
6-Hydroxy Nicorandil |
113743-17-2 |
C8H9N3O5 |
 |
TRANS-イトラコナゾール |
252964-65-1 |
C35H38Cl2N8O4 |
 |
N-(2-Pyridyl)oxamic Acid |
13120-39-3 |
C7H6N2O3 |
 |
(trans)-4-Propyl-1-methyl-L-proline |
13380-36-4 |
C9H17NO2 |
 |
N-Nordextromethorphan
|
1531-23-3 |
C17H23NO |
 |
(S,S,R,R)-オリスタット |
111466-62-7 |
C29H53NO5 |
 |
17β-Carboxy-17-desoxy Dexamethasone |
75262-69-0 |
C21H27FO4 |
 |
1-(dimethoxymethyl)-3-methoxybenzene |
59276-28-7 |
C10H14O3 |
 |
Benazepril impurity A |
|
C24H28N2O5 |
![3S,4R-4-[phenyl-1-methylpiperidinyl] methanol](/CAS/20180906/GIF/176022-03-0.gif) |
3S,4R-4-[phenyl-1-methylpiperidinyl] methanol |
176022-03-0 |
C13H19NO |
![トルセミド関連化合物B (N-[(N-ブチルアミノ)カルボニル]-4-[(3-メチルフェニル)アミノ]-3-ピリジンスルホンアミド)](/CAS/GIF/160972-33-8.gif) |
トルセミド関連化合物B (N-[(N-ブチルアミノ)カルボニル]-4-[(3-メチルフェニル)アミノ]-3-ピリジンスルホンアミド) |
160972-33-8 |
C17H22N4O3S |
 |
(R)-N-DeMethyl Dapoxetine |
1202160-36-8 |
C20H21NO |
![Budesonide Related Compound E (16alpha,17-[butylidenebis(oxy)]-11Beta,21-dihydroxypregna-1,4,14-triene-3,20-dione)](/CAS/GIF/131918-64-4.gif) |
Budesonide Related Compound E (16alpha,17-[butylidenebis(oxy)]-11Beta,21-dihydroxypregna-1,4,14-triene-3,20-dione) |
131918-64-4 |
C25H32O6 |
 |
2-(ベンジルメチルアミノ)-3',4'-ジヒドロキシアセトフェノン |
36467-25-1 |
C16H17NO3 |
 |
2'-O-(5'-Deoxy-β-D-ribofuranosyl) Capecitabine |
1262133-66-3 |
C20H30FN3O9 |
 |
4-Defluoro-4-hydroxy Gefitinib |
847949-50-2 |
C22H25ClN4O4 |
 |
Desethyl Sildenafil |
139755-91-2 |
C20H26N6O4S |
 |
N-Desisopropyl-N-forMyl Bisoprolol |
1346602-59-2 |
C16H25NO5 |
 |
N-DesMethyl Olopatadine |
113835-92-0 |
C20H21NO3 |
 |
TiMolol IMpurity E |
1026075-53-5 |
C17H26N4O6S |